CIMG Inc. faces Nasdaq delisting, moves to OTC

CIMG Inc. reported that a Nasdaq Hearings Panel has decided to delist its common stock from The Nasdaq Stock Market after the company failed to meet Nasdaq Listing Rules 5550(a)(2), 5250(c)(1), 5550(b)(1), and 5620(a).

Rhea-AI Filing Summary

CIMG Inc. reported that a Nasdaq Hearings Panel has decided to delist its common stock from The Nasdaq Stock Market after the company failed to meet Nasdaq Listing Rules 5550(a)(2), 5250(c)(1), 5550(b)(1), and 5620(a). Trading in the common stock was suspended at the open on March 6, 2026. The company has 15 calendar days from the March 4, 2026 decision to request review by the Nasdaq Listing and Hearing Review Council and currently expects to appeal, but there is no assurance of success. If no timely review is requested, or any appeal fails, Nasdaq is expected to file Form 25 with the SEC to remove the stock from Nasdaq listing and registration. As of March 6, 2026, FINRA has assigned the symbol “CIMG,” and the common stock may be quoted and traded in the over-the-counter market under that symbol.

Insights

Equity market structure analyst

Nasdaq delisting moves CIMG to OTC trading with added risk.

The decision by a Nasdaq Hearings Panel to delist CIMG Inc. after failures to meet several listing rules is a meaningful downgrade in trading venue. Suspension of trading on Nasdaq from March 6, 2026, ends access to that exchange’s liquidity and visibility.

The company can request review of the March 4, 2026 decision within 15 calendar days and expects to appeal, but the text explicitly notes there is no assurance of success. If review is not requested or fails, Nasdaq is expected to file Form 25 to remove the stock from Nasdaq listing and registration.

FINRA’s assignment of the “CIMG” symbol and indication that the common stock may trade over the counter from March 6, 2026 keeps a trading venue available, but over-the-counter markets typically involve different liquidity, pricing dynamics, and investor access compared with a national securities exchange.

8-K Event Classification

Item 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

1 item

Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Securities

The company received a delisting notice, failed to satisfy a continued-listing rule or standard, or transferred its listing.

FAQ

What Nasdaq action did CIMG Inc. (IMG) disclose in this 8-K?

CIMG Inc. disclosed that a Nasdaq Hearings Panel decided to delist its common stock from The Nasdaq Stock Market. The decision followed failures to comply with Nasdaq Listing Rules 5550(a)(2), 5250(c)(1), 5550(b)(1), and 5620(a), leading to suspension of trading on March 6, 2026.

Why is CIMG Inc.’s common stock being delisted from Nasdaq?

The stock is being delisted because CIMG Inc. failed to comply with Nasdaq Listing Rules 5550(a)(2), 5250(c)(1), 5550(b)(1), and 5620(a). A Nasdaq Hearings Panel determined these deficiencies warranted removal of the company’s common stock from The Nasdaq Stock Market under Nasdaq’s continued listing standards.

When was trading in CIMG Inc. shares suspended on Nasdaq?

Trading in CIMG Inc.’s common stock was suspended at the open of trading on March 6, 2026. This suspension followed the Nasdaq Hearings Panel’s March 4, 2026 decision to delist the shares for noncompliance with several Nasdaq Listing Rules governing price, reporting, financial standards, and shareholder meetings.

Can CIMG Inc. appeal the Nasdaq delisting decision?

Yes. CIMG Inc. has 15 calendar days from the March 4, 2026 Panel decision to request review by the Nasdaq Listing and Hearing Review Council. The company currently expects to appeal, but the disclosure clearly states there can be no assurance that any such appeal will be successful.

What happens if CIMG Inc. does not successfully appeal the delisting?

If CIMG Inc. does not timely request review, or if any appeal is unsuccessful, Nasdaq is expected to file Form 25 with the SEC. Filing Form 25 would remove the company’s common stock from listing and registration on The Nasdaq Stock Market, formalizing its exit from that exchange.

Where will CIMG Inc. stock trade after the Nasdaq suspension?

As of March 6, 2026, CIMG Inc. received notice from FINRA that the symbol “CIMG” had been assigned to its common stock. The disclosure states that, from that date, the common stock may be quoted and traded in the over-the-counter market under the “CIMG” symbol.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/09/2026 - 04:05 PM Learn about SEC filing dates

false 0001527613 0001527613 2026-03-04 2026-03-04 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): March 4, 2026

CIMG Inc.

(Exact name of registrant as specified in its charter)

Nevada		001-39338		38-3849791
(State or other jurisdiction of incorporation or organization		(Commission File No.)		(IRS Employer Identification No.)

Room R2, FTY D, 16/F, Kin Ga Industrial Building,

9 San On Street, Tuen Mun, Hong Kong

(Address of principal executive offices) 0000

+ 852 70106695

(Registrant’s telephone number, including area code)

N/A

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock, $0.00001 par value		IMG		The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

On March 4, 2026, CIMG Inc. (the “Company”) received written notice from The Nasdaq Stock Market LLC (“Nasdaq”) that the Nasdaq Hearings Panel (the “Panel”) had determined to delist the Company’s common stock, par value $0.00001 per share (the “Common Stock”) from The Nasdaq Stock Market due to the Company’s failures to comply with Nasdaq Listing Rules 5550(a)(2), 5250(c)(1), 5550(b)(1), and 5620(a). Trading in the Company’s Common Stock was suspended at the open of trading on March 6, 2026.

The Company has 15 calendar days from the date of the Panel’s decision to request that the Nasdaq Listing and Hearing Review Council review the Panel’s decision. The Company currently expects to appeal the Panel’s decision within the applicable period. There can be no assurance that any such appeal will be successful. If the Company does not timely request further review, or if any such appeal is unsuccessful, Nasdaq is expected to file a Form 25 with the U.S. Securities and Exchange Commission (the “SEC”) to remove the Company’s Common Stock from listing and registration on The Nasdaq Stock Market.

On March 6, 2026, the Company received a letter from Department of Market Operations of the Financial Industry Regulatory Authority, Inc. (“FINRA”), dated March 5, 2026, notifying the Company that the symbol “CIMG” had been assigned to the Common Stock. As of March 6, 2026, the Common Stock may be quoted and traded in the over-the-counter market under the symbol “CIMG.”

This Current Report on Form 8-K contains forward-looking statements within the meaning of the federal securities laws, including statements regarding the Company’s intention to appeal the Panel’s decision and the expected timing and occurrence of any filing of Form 25. These forward-looking statements involve known and unknown risks and uncertainties and are based on the Company’s current expectations and assumptions. Actual results may differ materially from those expressed or implied by such forward-looking statements. The Company undertakes no obligation to update any forward-looking statements except as required by law.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

		CIMG Inc.
Dated:	March 9, 2026	By:	/s/ Jianshuang Wang
		Name:	Jianshuang Wang
		Title:	Chief Executive Officer

Filing Exhibits & Attachments

3 documents

Other Documents

• EX-101 XBRL SCHEMA FILE 2.9 KB
• EX-101 XBRL LABEL FILE 33.4 KB
• EX-101 XBRL PRESENTATION FILE 21.8 KB